Regulatory protein:
OGT	S306-p
PLK1	S385-p
PRP4	S66-p , T74-p
TBK1	T74-p , S184-p , S306-p , S385-p

Treatment:
antibody	S66-p , S67-p , T74-p , T154-p , T160-p
AZD1152	S378-p
BI2536	S250-p , S378-p , S385-p
BI_4834	S66-p , S67-p , S79-p , T208-p , S378-p
dasatinib	S66-p , S67-p , T74-p
EGF	S66-p , S67-p , T137-p , S156-p , T208-p
FGF7	Y351-p
ischemia	S66-p , T208-p , S385-p
lapatinib	T74-p
LRRK2-IN-1	T74-p , S306-p
MEK_inhibitor_I	S66-p , S67-p
metastatic potential	S66-p , S67-p , S306-p
metformin	S59-p , S66-p , S67-p , T74-p , S156-p , T160-p , S385-p
MG132	K389-ub , K393-ub
MG132_withdrawal	T208-p
MLN8054	S306-p , S315-p , S385-p
nocodazole	S59-p , T74-p , S156-p , T160-p , T208-p , S306-p , T312-p , S315-p , S378-p
rapamycin	S66-p , S67-p
selumetinib	S156-p , S158-p
U0126	S156-p
vemurafenib	S156-p
ZM447439	S378-p